Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 11
Submit an article Journal homepage
284
Views
6
CrossRef citations to date
0
Altmetric
Letters to the Editor

Flow cytometric demonstration of decrease in bone marrow leukemic blasts after ‘Day 14’ without further therapy in acute myeloid leukemia

Xueyan ChenDepartment of Laboratory Medicine, University of Washington, Seattle, WA, USA; Correspondence[email protected]
,
Megan OthusDepartment of Biostatistics and Biomathematics, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;
,
Brent L. WoodDepartment of Laboratory Medicine, University of Washington, Seattle, WA, USA;
,
Roland B. WalterClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; ;Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA; ;Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA
,
Mary-Elizabeth M. PercivalClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; ;Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA;
,
Pamela S. BeckerClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; ;Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA; ;Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA
,
Paul C. HendrieDivision of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA;
,
Frederick R. AppelbaumClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; ;Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA
&
Elihu H. EsteyClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; ;Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA; ;Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA
 show all
Pages 2717-2719 | Received 09 Dec 2016, Accepted 26 Feb 2017, Published online: 28 Mar 2017

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L. Redner, Annie Im, Kathleen A. Dorritie, Alison Sehgal, James Rossetti, Nidhi Aggarwal, Melissa Saul, Michael Boyiadzis & Nathanael G. Bailey. (2023) Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy. Leukemia & Lymphoma 64:3, pages 750-752.
Read now
Michael Kluk. (2017) MRD in AML: a role for detecting leukemic blasts at day 14 post-induction chemotherapy?. Leukemia & Lymphoma 58:11, pages 2521-2522.
Read now

Articles from other publishers (4)

Alexander P. Hoffmann, Ashley L. Besch, Megan Othus, Linde M. Morsink, Brent L. Wood, Marco Mielcarek, Elihu H. Estey, Frederick R. Appelbaum & Roland B. Walter. (2019) Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia. Bone Marrow Transplantation 55:3, pages 669-672.
Crossref
Omer Jamy, Charles Bodine, Devi Sampat, Rehan Sarmad, Awal Chadha, Pankit Vachhani, Nikolaos Papadantonakis & Antonio Di Stasi. (2020) Observation Versus Immediate Reinduction for Acute Myeloid Leukemia Patients With Indeterminate Day 14 Bone Marrow Results. Clinical Lymphoma Myeloma and Leukemia 20:1, pages 31-38.
Crossref
Wenbin Xiao, Kseniya Petrova-Drus & Mikhail Roshal. (2019) Optimal Measurable Residual Disease Testing for Acute Myeloid Leukemia. Surgical Pathology Clinics 12:3, pages 671-686.
Crossref
Francesco Buccisano, Christopher S. Hourigan & Roland B. Walter. (2017) The Prognostic Significance of Measurable (“Minimal”) Residual Disease in Acute Myeloid Leukemia. Current Hematologic Malignancy Reports 12:6, pages 547-556.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.